Clinical Trials@2x
  • News

    Most Read

    • Lilly’s bamlanivimab prevents Covid-19 at nursing homes in BLAZE-2 trial
    • Moderna begins dosing in Covid-19 vaccine study in Japan
    • Reify Health extends StudyTeam platform availability for clinical trials

    Most Recent

    Clinical Trials

    Lilly’s bamlanivimab prevents Covid-19 at nursing homes in BLAZE-2 trial

    22 Jan 2021
  • Analysis

    Sections

    • Features
    • Comment
    • Projects

    Most Read

    • Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy
    • Teva and MedinCell Looking to Enter Increasingly Competitive LAI Schizophrenia Market
    • Novo Nordisk’s makes strides into Alzheimer’s with anti-diabetic drug

    Most Recent

    Clinical Trials

    Biogen’s Spinraza set to increase its chances to maintain a strong position in spinal muscular atrophy

    12 Jan 2021
  • Sectors

    Sections

    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices

    Most Read

    • NIH reports full-dose blood thinners improve Covid-19 outcome
    • Adastra eyes CRO pitches for Phase II trial of anticancer candidate; initiates $45m Series B fundraising, exec says
    • Senhwa Biosciences initiates enrolment in Covid-19 drug trial

    Most Recent

    Clinical Trials

    NIH reports full-dose blood thinners improve Covid-19 outcome

    25 Jan 2021
  • Themes
  • Deals

    Most Read

    • Investment firm GI Partners closes Clinical Ink acquisition
    • Investment firm GI Partners to acquire minority interest in Clinical Ink
    • IVI and SNU partner to trial Inovio’s Covid-19 vaccine in Korea

    Most Recent

    Clinical Trials

    Investment firm GI Partners closes Clinical Ink acquisition

    27 Aug 2020
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos

    Most Read

    • Linari NanoTech
    • OpenClinica
    • Strategikon Pharma

    Most Recent

    Linari NanoTech

    19 Jan 2021
  • Magazine
  • Events
Menu
  • News
  • Analysis
    • Features
    • Comment
    • Projects
  • Investment
  • Sectors
    • Clinical Trials
    • Approvals
    • Clinical Research
    • Operations
    • Outsourcing
    • Supply Chain
    • Cold Chain
    • Data Management
    • Medical Devices
  • Deals
  • Tech
  • Disruption
  • Coronavirus
Partners
  • Accelerating Clinical Trials
  • Simplifying Clinical Trials
Tools
  • Companies
    • Company A-Z
    • Company Categories
    • Product & Services
    • Company Releases
    • White Papers
    • Videos
  • Awards
  • Events
  • Magazine
The Company
  • About Us
  • Contact Us
  • Advertise With Us
  • Visit GlobalData
  • Login
  • Register
  • Login
  • Register
Biophytis starts Phase II/III Covid-19 trial of Sarconeos in Belgium

Biophytis starts Phase II/III Covid-19 trial of Sarconeos in Belgium

Biotechnology firm Biophytis has started enrolment and dosing of patients in a Phase II/III clinical...

2nd September 2020
Biophytis and SGS partner to test Sarconeos in Covid-19 patients

Biophytis and SGS partner to test Sarconeos in Covid-19 patients

French biotech firm Biophytis will assess its Sarconeos (BIO101) drug as a treatment for respiratory...

8th July 2020
UCB reports positive data from BE READY trial of bimekizumab

UCB reports positive data from BE READY trial of bimekizumab

UCB has reported positive results from the Phase III BE READY clinical trial of its...

18th November 2019
Themis Bioscience and CEPI trial Lassa fever vaccine

Themis Bioscience and CEPI trial Lassa fever vaccine

Themis Bioscience and the Coalition for Epidemic Preparedness Innovations (CEPI) have commenced a Phase I...

30th October 2019
UCB’s trial of bimekizumab in psoriasis patients meets goals

UCB’s trial of bimekizumab in psoriasis patients meets goals

UCB has announced that the Phase III BE VIVID clinical trial of its bimekizumab met...

18th October 2019
Vaccitech begins Phase IIb universal flu vaccine trial in Belgium

Vaccitech begins Phase IIb universal flu vaccine trial in Belgium

UK-based Vaccitech has started treating patients with influenza A vaccine MVA-NP+M1 (VTP-100) in a Phase...

7th June 2019
MorphoSys and Galapagos launch Phase II atopic dermatitis trial

MorphoSys and Galapagos launch Phase II atopic dermatitis trial

MorphoSys and Galapagos have commenced a Phase II clinical trial, in alliance with Novartis Pharma,...

25th April 2019
OSE Immunotherapeutics to study cancer drug in France and Belgium

OSE Immunotherapeutics to study cancer drug in France and Belgium

OSE Immunotherapeutics has secured authorisation from the French and Belgian regulatory authorities to conduct a...

6th March 2019
argenx begins dosing in Phase III myasthenia gravis trial

argenx begins dosing in Phase III myasthenia gravis trial

Biotechnology company argenx has started dosing patients in a Phase III clinical trial of its...

7th September 2018
FluGen doses first subject in new study of M2SR for influenza

FluGen doses first subject in new study of M2SR for influenza

FluGen has dosed the first subject in a new clinical trial evaluating the M2SR vaccine...

17th May 2018

Latest News

Clinical Trials

Montreal Heart Institute reports positive results from Covid-19 trial

25 Jan 2021
Technology

Telemedicine to benefit the most from remote patient monitoring tools: Poll

25 Jan 2021
Clinical Trials

NIH reports full-dose blood thinners improve Covid-19 outcome

25 Jan 2021
Clinical Trials

Senhwa Biosciences initiates enrolment in Covid-19 drug trial

25 Jan 2021

Company A-Z

View All

Company Releases

View All

White Papers

View All

Videos

View All
CTArena_white-logo_

Powered by Pharma Tech Logo

  • About Us
  • Editorial Approach
  • Contact Us
  • Terms and Conditions
  • Privacy Policy

© Copyright 2021 Verdict Media Limited.

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more